跳至主要内容
临床试验/NCT01762189
NCT01762189已完成不适用

Multicenter Prospective Study on the Incidence and Risk Factors of Neonatal Hyperbilirubinemia in Term and Late-preterm Chinese Infants

Nanjing Medical University14 个研究点 分布在 1 个国家目标入组 13,157 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
13,157
试验地点
14
主要终点
The incidence of severe neonatal hyperbilirubinemia

研究概览

简要总结

Thirteen hospitals in China will participate in the study, which aims to provide data on serum bilirubin levels in the first 168 hr after birth in term and late-preterm neonates, and estimate the incidence of severe neonatal hyperbilirubinemia and the underlying causes.

We hypothesize that the study can be value in identifying and implementing strategies for risk reduction.

详细描述

Neonatal hyperbilirubinemia resulting in clinical jaundice is a common problem among infants, particularly during the first weeks of life.

Information about the incidence and risk factors of neonatal jaundice is not available from China where is one of the highest countries of the incidence of severe neonatal hyperbilirubinemia.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Day 至 28 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Term or late-preterm newborn infants with GAs of ≥35 weeks and birth weights of ≥2,000 g were included.

排除标准

  • All sick newborn infants who were admitted to the intensive care unit.

结局指标

主要结局

The incidence of severe neonatal hyperbilirubinemia

时间窗: At the 28 days after birth

Significant hyperbilirubinemia was defined as any TSB level that exceeded the hour-specific threshold value for phototherapy, according to the guidelines presented by the American Academy of Pediatrics.

次要结局

  • Number of participants with risk factors associated with severe neonatal hyperbilirubinemia(At the 28 days after birth)

研究者

发起方
Nanjing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhangbin Yu

Principal Investigator

Nanjing Medical University

研究点 (14)

Loading locations...

相似试验